Citius Pharma Stock (NASDAQ:CTXR), Quotes and News Summary

Q: What sector and industry does Citius Pharma (CTXR) operate in?

Citius Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Citius Pharma Stock (NASDAQ: CTXR) stock price, news, charts, stock research, profile.

Open	$0.697
Close	-
Volume / Avg.	365.454K / 850.642K
Day Range	0.681 - 0.720
52 Wk Range	0.600 - 1.619
Market Cap	$113.554M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	8.46%
Days to Cover	17.66

Recent News

Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.

Lisa Levin

Why Citius Pharmaceuticals Stock Is Plunging Today?

The FDA issued a Complete Response Letter regarding Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Biologics License Application (BLA) seeking approval for denileukin diftitox (Lymphir), an engineered IL-2-diphtheria toxin fusion protein for relapsed or refractory cutaneous T-cell lymphoma (CTCL)

Vandana Singh

Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Gainers

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Citius Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Citius Pharma (CTXR) stock?

You can purchase shares of Citius Pharma (NASDAQ: CTXR) through any online brokerage.

View our list of the best stock brokerages.

Who are Citius Pharma's (CTXR) competitors?

Other companies in Citius Pharma’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS) and Alimera Sciences (NASDAQ:ALIM).

What is the target price for Citius Pharma (CTXR) stock?

The latest price target for Citius Pharma (NASDAQ: CTXR) was reported by HC Wainwright & Co. on Wednesday, February 14, 2024. The analyst firm set a price target for 4.00 expecting CTXR to rise to within 12 months (a possible 455.63% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for Citius Pharma (CTXR)?

The stock price for Citius Pharma (NASDAQ: CTXR) is $0.7199 last updated Today at April 25, 2024 at 9:29 AM EDT.

Does Citius Pharma (CTXR) pay a dividend?

There are no upcoming dividends for Citius Pharma.

When is Citius Pharma (NASDAQ:CTXR) reporting earnings?

Citius Pharma’s Q2 earnings are confirmed for Friday, May 10, 2024.

Is Citius Pharma (CTXR) going to split?

There is no upcoming split for Citius Pharma.

What sector and industry does Citius Pharma (CTXR) operate in?

Citius Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-